WOAG
WITHDRAWAL OF ATTORNEY GRANTED
09/30/2025
Back to search
Official data from USPTO
RASNA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RASNA THERAPEUTICS
ST13
US500000086662422Class
5, 42, 44
Filing
86662422
Registration
4904535
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
10/10/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
06/15/2015
Registration date
02/23/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
10/10/2025
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
LOBO,DEBORAH E
Law office
L90
Holders and representatives
Holders
Rasna Therapeutics Limited
Rasna Therapeutics Limited
Representatives
Rasna Therapeutics Limited
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsoncological preparations; Pharmaceutical preparations for use in the treatment of cancer
Class 42
Pharmaceutical research and development; pharmaceutical drug development; Research and development of new productsdrugs and technology in the field of oncology; scientific research and development; drug discovery services; providing medical research and scientific research information in the field of oncology; informationadvisory and consultancy services in relation to all the aforesaid services
Class 44
Pharmaceutical advice; pharmaceutical consultation; dispensing of pharmaceuticals; provision of pharmaceutical information; informationadvisory and consultancy services in relation to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
28 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
09/30/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
07/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/07/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/23/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/07/2023
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/07/2023
E815
TEAS SECTION 8 & 15 RECEIVED
08/19/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/23/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/08/2015
PUBO
PUBLISHED FOR OPPOSITION
12/08/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/18/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/30/2015
ALIE
ASSIGNED TO LIE
10/29/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
09/23/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/23/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
09/23/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/23/2015
DOCK
ASSIGNED TO EXAMINER
09/23/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/18/2015
NWAP
NEW APPLICATION ENTERED
06/18/2015
Continuous trademark protection
Get notified about every new filing that threatens RASNA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.